Caricamento...
A Single Chimpanzee-Human Neutralizing Monoclonal Antibody Provides Post-exposure Protection Against Type 1 and Type 2 Polioviruses
BACKGROUND: Development of anti-poliovirus therapies to complement vaccination is an urgent priority. A number of antiviral drugs are in development. Recently we have developed human monoclonal antibodies that could be used for treatment of chronically infected individuals and emergency response to...
Salvato in:
| Pubblicato in: | J Clin Virol |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4378240/ https://ncbi.nlm.nih.gov/pubmed/25766984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcv.2015.01.023 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|